| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Carcinogenesis |
Departments of Anatomy [X. W., H. F., Y. C. W., A. L. M. C., S. W. T.] and Biochemistry [D-Y. J., R. W. M. N.], Faculty of Medicine, University of Hong Kong, Hong Kong
Chromosome instability is a commonly observed feature in ovarian carcinoma.Mitotic checkpoint controls are thought to be essential for accurate chromosomal segregation, and MAD2 is a key component of this checkpoint. In this study, we investigated the competence of the mitotic checkpoint and its relationship to the expression of MAD2 protein in seven ovarian cancer cell lines. We found that a significant number (43%, three of seven cell lines) of the tested ovarian cancer cells failed to arrest in the G2-M phase of the cell cycle in response to microtubule disruption. This loss of mitotic checkpoint control was associated with reduced expression of the MAD2 protein. To additionally understand the significance of the MAD2 to mitotic checkpoint control, we established an inducible expression system in which MAD2 was induced by the addition of ponasterone A. Notably, the induced expression of MAD2 in two checkpoint-defective ovarian cancer cell lines led to the restoration of mitotic checkpoint response to spindle-disrupting agents. Taken together, our findings suggest that the steady-state amount of MAD2 inside cells may represent a molecular switch for mitotic checkpoint control. This provides a novel insight into the molecular basis of CIN in ovarian carcinoma and has implications for effective use of checkpoint-targeting drugs.
This article has been cited by other articles:
|
|
 |
|
  A. Stolz, C. Vogel, V. Schneider, N. Ertych, A. Kienitz, H. Yu, and H. Bastians Pharmacologic Abrogation of the Mitotic Spindle Checkpoint by an Indolocarbazole Discovered by Cellular Screening Efficiently Kills Cancer Cells Cancer Res., May 1, 2009; 69(9): 3874 - 3883. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. M.-F. Sze, Y.-P. Ching, D.-Y. Jin, and I. O.-L. Ng Role of a Novel Splice Variant of Mitotic Arrest Deficient 1 (MAD1), MAD1{beta}, in Mitotic Checkpoint Control in Liver Cancer Cancer Res., November 15, 2008; 68(22): 9194 - 9201. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Niikura, A. Dixit, R. Scott, G. Perkins, and K. Kitagawa BUB1 mediation of caspase-independent mitotic death determines cell fate J. Cell Biol., July 10, 2007; 178(2): 283 - 296. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Iwanaga, Y.-H. Chi, A. Miyazato, S. Sheleg, K. Haller, J.-M. Peloponese Jr., Y. Li, J. M. Ward, R. Benezra, and K.-T. Jeang Heterozygous Deletion of Mitotic Arrest-Deficient Protein 1 (MAD1) Increases the Incidence of Tumors in Mice Cancer Res., January 1, 2007; 67(1): 160 - 166. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Vogel, C. Hager, and H. Bastians Mechanisms of Mitotic Cell Death Induced by Chemotherapy-Mediated G2 Checkpoint Abrogation Cancer Res., January 1, 2007; 67(1): 339 - 345. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Mondal, S. Sengupta, C. K. Panda, S. M. Gollin, W. S. Saunders, and S. Roychoudhury Overexpression of Cdc20 leads to impairment of the spindle assembly checkpoint and aneuploidization in oral cancer Carcinogenesis, January 1, 2007; 28(1): 81 - 92. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. K. Lee, R. T.P. Poon, A. P. Yuen, M. T. Ling, X. H. Wang, Y. C. Wong, X. Y. Guan, K. Man, Z. Y. Tang, and S. T. Fan Regulation of Angiogenesis by Id-1 through Hypoxia-Inducible Factor-1{alpha}-Mediated Vascular Endothelial Growth Factor Up-regulation in Hepatocellular Carcinoma Clin. Cancer Res., December 1, 2006; 12(23): 6910 - 6919. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Ren, A. Kan, S. H. Leong, L. L. P. J. Ooi, K.-T. Jeang, S. S. Chong, O. L. Kon, and C. G. L. Lee FAT10 Plays a Role in the Regulation of Chromosomal Stability J. Biol. Chem., April 21, 2006; 281(16): 11413 - 11421. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. W. Cheung, A. C.S. Chun, Q. Wang, W. Deng, L. Hu, X.-Y. Guan, J. M. Nicholls, M.-T. Ling, Y. Chuan Wong, S. Wah Tsao, et al. Inactivation of Human MAD2B in Nasopharyngeal Carcinoma Cells Leads to Chemosensitization to DNA-Damaging Agents. Cancer Res., April 15, 2006; 66(8): 4357 - 4367. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Yuan, Y. Xu, J.-H. Woo, Y. Wang, Y. K. Bae, D.-S. Yoon, R. P. Wersto, E. Tully, K. Wilsbach, and E. Gabrielson Increased Expression of Mitotic Checkpoint Genes in Breast Cancer Cells with Chromosomal Instability Clin. Cancer Res., January 15, 2006; 12(2): 405 - 410. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-T. Ling, T. C.M. Lau, C. Zhou, C. W. Chua, W. K. Kwok, Q. Wang, X. Wang, and Y.-C. Wong Overexpression of Id-1 in prostate cancer cells promotes angiogenesis through the activation of vascular endothelial growth factor (VEGF) Carcinogenesis, October 1, 2005; 26(10): 1668 - 1676. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. O. Cowley, G. W. Muse, and T. Van Dyke A Dominant Interfering Bub1 Mutant Is Insufficient To Induce or Alter Thymic Tumorigenesis In Vivo, Even in a Sensitized Genetic Background Mol. Cell. Biol., September 1, 2005; 25(17): 7796 - 7802. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. K. Kwok, M.-T. Ling, T.-W. Lee, T. C.M. Lau, C. Zhou, X. Zhang, C. W. Chua, K. W. Chan, F. L. Chan, C. Glackin, et al. Up-Regulation of TWIST in Prostate Cancer and Its Implication as a Therapeutic Target Cancer Res., June 15, 2005; 65(12): 5153 - 5162. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Mitotic Checkpoint Control in Ovarian Cancer Cells Cancer Res., March 1, 2005; 65(5): 2045 - 2045. [Full Text] [PDF]
|
|
|
|
|
|
H. W. Cheung, D.-Y. Jin, M.-t. Ling, Y. C. Wong, Q. Wang, S. W. Tsao, and X. Wang Mitotic Arrest Deficient 2 Expression Induces Chemosensitization to a DNA-Damaging Agent, Cisplatin, in Nasopharyngeal Carcinoma Cells Cancer Res., February 15, 2005; 65(4): 1450 - 1458. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Vogel, A. Kienitz, R. Muller, and H. Bastians The Mitotic Spindle Checkpoint Is a Critical Determinant for Topoisomerase-based Chemotherapy J. Biol. Chem., February 11, 2005; 280(6): 4025 - 4028. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-J. Jeong, H.-J. Shin, S.-J. Kim, G.-H. Ha, B.-I. Cho, K.-H. Baek, C.-M. Kim, and C.-W. Lee Transcriptional Abnormality of the hsMAD2 Mitotic Checkpoint Gene Is a Potential Link to Hepatocellular Carcinogenesis Cancer Res., December 1, 2004; 64(23): 8666 - 8673. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Myung, S. Smith, and R. D. Kolodner Mitotic checkpoint function in the formation of gross chromosomal rearrangements in Saccharomyces cerevisiae PNAS, November 9, 2004; 101(45): 15980 - 15985. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Zhang, W. Ma, Y.-H. Li, Y. Hou, S.-W. Li, X.-Q. Meng, X.-F. Sun, Q.-Y. Sun, and W.-H. Wang Intra-oocyte Localization of MAD2 and Its Relationship with Kinetochores, Microtubules, and Chromosomes in Rat Oocytes During Meiosis Biol Reprod, September 1, 2004; 71(3): 740 - 748. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Pati, B. R. Haddad, A. Haegele, H. Thompson, F. S. Kittrell, A. Shepard, C. Montagna, N. Zhang, G. Ge, S. K. Otta, et al. Hormone-Induced Chromosomal Instability in p53-Null Mammary Epithelium Cancer Res., August 15, 2004; 64(16): 5608 - 5616. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. J. P. L. Kops, D. R. Foltz, and D. W. Cleveland Lethality to human cancer cells through massive chromosome loss by inhibition of the mitotic checkpoint PNAS, June 8, 2004; 101(23): 8699 - 8704. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. W. Cheung, M.-t. Ling, S. W. Tsao, Y.C. Wong, and X. Wang Id-1-induced Raf/MEK pathway activation is essential for its protective role against taxol-induced apoptosis in nasopharyngeal carcinoma cells Carcinogenesis, June 1, 2004; 25(6): 881 - 887. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Bernstein, C. M. Payne, K. Kunke, C. L. Crowley-Weber, C. N. Waltmire, K. Dvorakova, H. Holubec, C. Bernstein, R. R. Vaillancourt, D. A. Raynes, et al. A proteomic study of resistance to deoxycholate-induced apoptosis Carcinogenesis, May 1, 2004; 25(5): 681 - 692. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Sudo, M. Nitta, H. Saya, and N. T. Ueno Dependence of Paclitaxel Sensitivity on a Functional Spindle Assembly Checkpoint Cancer Res., April 1, 2004; 64(7): 2502 - 2508. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Michel, E. Diaz-Rodriguez, G. Narayan, E. Hernando, V. V. V. S. Murty, and R. Benezra Complete loss of the tumor suppressor MAD2 causes premature cyclin B degradation and mitotic failure in human somatic cells PNAS, March 30, 2004; 101(13): 4459 - 4464. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Akiyama, T. Hideshima, M. A. Shammas, T. Hayashi, M. Hamasaki, Y.-T. Tai, P. Richardson, S. Gryaznov, N. C. Munshi, and K. C. Anderson Effects of Oligonucleotide N3'->P5' Thio-phosphoramidate (GRN163) Targeting Telomerase RNA in Human Multiple Myeloma Cells Cancer Res., October 1, 2003; 63(19): 6187 - 6194. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. C. S. Chun and D.-Y. Jin Transcriptional Regulation of Mitotic Checkpoint Gene MAD1 by p53 J. Biol. Chem., September 26, 2003; 278(39): 37439 - 37450. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Zhou, J. Yao, and H. C. Joshi Attachment and tension in the spindle assembly checkpoint J. Cell Sci., September 15, 2002; 115(18): 3547 - 3555. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
